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intrODuctiOn
Congenital hypothyroidism (CH) has an incidence in the 
UK of about 1 in 3500 births1 and is an important cause 
of preventable mental handicap.2 Newborn screening by 
measuring capillary thyroid stimulating hormone (TSH) 
on heel prick testing has revolutionised the outlook for CH 
in developed countries but remains a challenge in resource- 
limited parts of the world.
CH can be classified according to aetiology and duration. 
Primary CH is traditionally categorised as thyroid dysgen-
esis and thyroid dyshormonogenesis.3 Thyroid dysgenesis 
comprises ectopia, where the gland has failed to migrate 
normally, athyreosis in which no thyroid tissue is identifiable, 
and hypoplasia in a normally positioned, or eutopic, gland. 
Thyroid dyshormonogenesis refers to a group of inherited 
enzyme or other protein defects, with a structurally intact and 
usually enlarged eutopic gland.
Permanent CH must be distinguished from transient TSH 
elevation, the latter being common in sick or preterm 
infants.4 However, it is now recognised that some types 
of dyshormonogenesis such as DUOX2 deficiency, a 
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Objective: To compare two methods of assessing gland 
size on thyroid ultrasound in newborn infants with 
suspected congenital hypothyroidism (CH).
Methods: Images from infants with eutopic glands 
referred between 2007 and 2013 were evaluated blind by 
two sets of observers. Subjective gland size was catego-
rised as small, borderline- small, normal, borderline- large 
and large. Objective gland volume, calculated as the sum 
of each lobe using the prolate ellipsoid formula (length 
x width x depth x π/6), was put into corresponding 
categories: <0.8, 0.81–1.0, 1.1– <2.2, 2.2–2.4 and >2.4 ml, 
derived from normative Scottish data.
results: Of 36 infants, permanent CH was present in 17, 
transient CH in 17, status uncertain in 2. Mean (SD) intra-
observer error for thyroid volume measurement was 0.11 
(0.23) ml [8.3%]. Subjective assessment by two observers 
was discordant in only four (10.8%) infants. However, 
subjective vs objective evaluation was discordant in 14 
(39%). Eight (three permanent, five transient CH) had 
large glands subjectively but normal glands objectively; 
and six (four transient CH) had normal glands subjec-
tively but small glands objectively. The former infants all 
showed a single flattened curve to the anterior thyroid 
margin, giving an impression of bulkiness. Gland shape 
was normal in the latter infants.
conclusion: Neither subjective nor objective evaluation 
predicts permanent vs transient CH. Altered gland shape 
may confound both methods, and undermine use of the 
conventional formula for measuring lobe volume.
advances in knowledge: Until more refined methods are 
available for assessing thyroid size, both subjective and 
objective evaluation are recommended in CH.
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relatively common form in the UK,5 can result in both tran-
sient and permanent CH.6
Thyroid imaging is an integral part of the assessment of infants 
referred with TSH elevation. The European Society for Paedi-
atric Endocrinology (ESPE) guidelines recommend that either 
thyroid ultrasound or scintigraphy, or both modalities, should 
be carried out in suspected cases.7 It is particularly important 
to identify a eutopic thyroid gland in suspected CH; work from 
Rabbiosi and colleagues showing that only a third of children 
re- evaluated at 3 years needed to continue with L- thyroxine 
(L- T4) therapy.8
Assessment of thyroid size, while inapplicable in athyreosis and 
of limited value in ectopia, is important in CH with a eutopic 
gland, helping to establish aetiology and focus subsequent inves-
tigation. A small eutopic gland demands molecular genetic 
analysis to rule out mutations in one of the candidate genes 
for thyroid dysgenesis: PAX8, TSH receptor and NKX2.1.9 An 
enlarged gland in situ evokes causes such as iodine deficiency or 
dyshormonogenesis.10
Reference ranges for thyroid size in healthy newborn infants 
have been established in various countries, including Scotland.11 
The length, width and anteroposterior dimension of each thyroid 
lobe are measured (Figure  1a, b and c) and volume calculated 
by assuming the shape of a prolate ellipsoid and applying the 
formula length x width x anteroposterior dimension x π/6 (or a 
similar constant). Thyroid volume is then expressed as the sum 
of both lobes. The contribution of the thyroid isthmus to volume 
(Figure 1d) is ignored.11
While formal measurement of thyroid volume may be recom-
mended, subjective assessment of gland size by an experienced 
observer remains the norm in clinical practice. However, there 
are currently no data to validate either objective or subjective 
assessment of thyroid volume in pathological states, and no 
studies directly comparing the two methods.
We became aware of a potential discrepancy between subjec-
tive and objective thyroid assessment when an infant with 
Down syndrome in our centre was found to have a PAX8 
mutation resulting in permanent CH.12 The infant’s thyroid 
gland had been subjectively reported on ultrasound as “bulky,” 
implying increased size (Figure  2). However, when the lobes 
were measured while preparing the case for publication, thyroid 
volume was found to be at the lower end of the reference range.
This observation prompted the present study which aims to 
compare objective and subjective assessment of thyroid size in a 
group of infants with TSH elevation and eutopic glands in whom 
at least 6 years of follow up are available. The study also deter-
mines the intraobserver variability of objective measurement 
and the interobserver variability of subjective assessment.
Patients anD MethODs
Newborn screening for CH began in Scotland in 1979.13 In 1990, 
a database designed for gathering information and helping with 
follow up was established and has been maintained and audited 
since.1,13,14 From the outset, all infants referred on the programme 
have had venous blood taken to confirm TSH elevation (paedi-
atric reference range 0.3–5.5 mU/L) and to gauge the severity 
of hypothyroidism by measuring free T4 (paediatric reference 
Figure 1. (a, b, c and d) Thyroid ultrasound images of normal infant showing width and anteroposterior measurement of right 
lobe (a), left lobe (b), length of right lobe (c) and anteroposterior measurement of the isthmus (d). Note that measurement of the 
thyroid isthmus is not factored into the formula for calculating thyroid volume.
3 of 12 birpublications.org/bjro BJR Open;2:20200001
BJR|OpenOriginal research: Subjective vs objective evaluation of thyroid size in CH
range 9–26 pmol l−1). An assay for serum thyroglobulin (Tg), a 
protein synthesised exclusively in the thyroid, has been avail-
able in Glasgow since 2004 using IMMULITE 2000 (Siemens), 
FS 2 µg l−1, reference range 63–403 µg l−1 based on Czech data 
from 26 healthy singleton infants (Neumann et al, 2020 in prepa-
ration). Since then, Tg measurement has been carried out by 
some but not all centres, at the clinician’s discretion.
Thyroid imaging in suspected CH has been practised throughout 
Scotland with varying consistency since screening began. Since 
1999, a comprehensive service offering both thyroid ultrasound 
and radioisotope scanning has been established and developed 
in the Royal Hospital for Sick Children in Glasgow15,16 . Of the 
17–41 (median 28) referrals per year in Scotland between 1999 
and 2019, dual scanning has been offered to infants from the 
West of Scotland and extended to other Scottish Health Boards 
on request.
In the present study, thyroid ultrasound images of all newborn 
infants with TSH elevation referred to our centre for imaging 
between 2007 and 2013, in whom a thyroid gland in situ (eutopic 
gland) had been identified, were reviewed using the Picture 
Archiving and Communications System (PACS), (Kodak Care-
stream, Carestream Health, Station Road, Hemel Hempstead, 
UK). Patients in whom good quality images of the entire thyroid 
gland were available were included.
Molecular genetic analysis had been carried out in selected cases 
at the clinicians’ discretion in Glasgow, Scotland, and Mainz, 
Germany. Genes analysed included those encoding the thyroid 
stimulating hormone receptor (TSH- R), Tg, Pendrin, the tran-
scription factor PAX8, and the enzymes thyroid peroxidase 
(TPO), DUOX.2 and DUOX.A2.
Ultrasound imaging was carried out using a Philips iU22 model 
(Koninklijke Philips Electronics N.V., Groenewoudsweg 1, 5621 
BA, Eindhoven, The Netherlands) featuring a 7–15 MHz hock-
eystick transducer. Radioisotope imaging used 99mTc Pertechn-
etate with a high- resolution pin hole collimator (either Siemens 
Symbia, Siemens Medical Solutions, 2501 North Barrington 
Road, Hoffman Estates, IL or Phillips Axis, Phillips Medical 
Systems, The Observatory, Castlefield Road, Reigate, Surrey, 
UK). When, despite using the widest field of view available, it 
was not possible to include the whole thyroid lobe, length was 
determined by extrapolation,
Evaluation of thyroid images
Two observers (MG and JJ), who were blinded to clinical details 
or previous reports, recorded the length, width and anteroposte-
rior dimension of each infant’s lobes on two separate occasions. 
Lobe volume was calculated as: (length x width x anteropos-
terior dimension x π/6)/1000 to give a value in millilitres and 
combined thyroid volume expressed as the sum of both lobes as 
previously described.17 In the present study, glands were clas-
sified as small, borderline- small, normal, borderline- large and 
large corresponding to volumes <0.8, 0.8–1.0, 1.01–< 2.2, 2.2–2.4 
and >2.4 ml, based on the normative Scottish data of Perry et al 
in which mean (SD) thyroid volume was 1.6 (0.4) ml.11
As a separate exercise, a radiographer and radiologist (MG and 
ES) independently assessed the ultrasound images subjectively, 
under blinded conditions, scoring glands as large, borderline- 
large, normal, borderline- small, or small. These observers then 
discussed their findings to reach an agreed score in each patient.
Finally, the available radioisotope (RIS) images were evaluated 
under blinded conditions on two occasions by a single radiol-
ogist (GI) and scored as showing absent, decreased, normal or 
increased uptake; and small, normal or increased volume. GI 
then reviewed all images with ES during a second session to 
reach a final evaluation.
In 2019, the thyroid status in each patient was revisited using 
Clinical Portal (https://www. ggc- clinicalportal. scot. nhs. uk/ 
concerto) and where necessary by contacting the relevant 
paediatrician.
Diagnostic classification of patients
A modification of the double- classification for CH previously 
described1 was applied, according to: (a) duration; and (b) 
aetiology.
Duration
CH was categorised as ‘permanent’ in patients who, by 2019 
were either still receiving L- T4 therapy or (in one case) who had 
persistent TSH elevation off treatment.
‘Transient’ CH was defined when normal venous free T4 and 
TSH values were recorded, either in patients in whom treatment 
had not been required, or after L- T4 had been withdrawn as a 
diagnostic challenge.
Figure 2. Thyroid ultrasound in an infant with Down syndrome 
and PAX8 mutation (patient P11 in Table 1 and Hermanns et al). 
Thyroid appears bulky but combined lobe volume is actually 
small at 0.78 ml (reference range 0.8–2.4 ml).
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Patients in whom the cause of CH had not been established and 
who remained on L- T4 pending diagnostic challenge were cate-
gorised as ‘Status uncertain‘.
Etiology
The term ‘dyshormonogenesis’ was applied to patients with 
either permanent or transient CH in whom there was either a 
molecular genetic diagnosis (e.g. TPO, Tg, DUOX.2 defect) or 
agreed gland size was increased or gland size was normal in 
the presence of at least three additional features consistent with 
dyshormonogenesis, comprising: increased size of gland on RIS, 
increased uptake on RIS, enlargement of the thyroid isthmus 
and increased vascularity on thyroid ultrasound; and markedly 
elevated Tg (>1000 µg l−1) at presentation.
Thyroid hypoplasia was defined as either permanent CH in a 
patient in whom gland size was agreed to be small on combined 
subjective or objective evaluation; or an objectively small or 
borderline- small gland in a patient with a gene disorder known 
to be associated with reduced thyroid volume such as PAX8 and 
TSH- R mutation.
The term ‘permanent CH of unknown cause’ was applied to 
patients in whom agreed gland size was objectively normal 
rather than small or large in a patient shown to be persistently 
hypothyroid on diagnostic challenge in the absence of features 
suggestive of dyshormonogenesis.
Statistical aspects
Intraobserver differences were calculated between the first 
and second measurement of combined thyroid volume for 
all infants. Correlation between the objective and subjec-
tive assessment of thyroid size was described as concordant; 
partially concordant if one category apart; and discordant if 
two categories apart.
Ethical aspects
All parents had given informed consent at the time of assess-
ment for the images to be stored and later assessed in an 
anonymised form. The study was registered with the Clinical 
Effectiveness Department at NHS Greater Glasgow & Clyde as 
a Quality Improvement Project. In 2019, Caldicott approval 
was obtained from the Guardian for NHS Greater Glasgow 
and Clyde to access patients on Clinical Portal, the Caldicott 
Guardian being a senior person in a given Health Board who is 
responsible for protecting the confidentiality of patient health 
and care information and ensuring that patient anonymity is 
maintained.
results
Stored images permitted measurement of both lobes in 37 of 
61 infants with TSH elevation who were recorded as having a 
eutopic gland during the study period. One infant with allo- 
immune thyroiditis from maternal antibodies and transient 
congenital hypothyroidism was excluded, since perithyroid 
oedema confounded both objective and subjective assessment 
in this patient (Figure 3).
Of the remaining 36 patients (21 males, 15 females) median 
(range) birthweight, gestation and age at thyroid ultrasound 
examination were 3220 (1440–4460) g, 39.5 (31–42) weeks and 
19 (7-62) days, respectively. Five infants were of low birth weight 
(<2500 g) and one preterm (<37 weeks) at 31 weeks gestation.
Categorisation and diagnostic classification 
(Tables 1 and 2)
Of the 36 study patients, 17 have permanent CH (P1-17) and 
their data are shown in Table  1. Table  2 gives details on 17 
patients with transient CH (T1-17), and in 2 (SU1-2) in whom 
status remains uncertain.
12 patients met the criteria for dyshormonogenesis of whom 
eight had permanent and four had transient CH, with molec-
ular genetic confirmation in seven comprising TPO (2), Tg (2), 
DUOX.2 (2) defect and Pendrin heterozygote (1).
The criteria for thyroid hypoplasia were met in 10 patients, 
eight with permanent and two with transient CH. TSH- R muta-
tion was found in four patients, homozygous in one (P14) and 
heterozygous in three (P10, P15, T15), one of whom (P15) has 
Down syndrome. Of note, radioisotope uptake was decreased 
or absent in all four patients. PAX8 mutation was found in two 
patients (P11, P17), including the index patient (P11) with Down 
syndrome.12 A further patient (T6), presented with TSH eleva-
tion on newborn screening, commenced L- T4 therapy, but then 
developed neuromotor symptoms and was found to have a dele-
tion proximal to the NKX2.1 gene, consistent with a variant of 
the brain–lung–thyroid syndrome.18 This patient’s thyroid func-
tion became normal off treatment at 4 years of age. Cause in the 
remaining three patients with thyroid hypoplasia (P12,13 and 
16), one of whom (P12) has Down syndrome, is unknown.
Amongst the nine patients with transient CH who were not 
categorised as having dyshormonogenesis or hypoplasia, cause 
was attributable to thyroid autoantibodies in three (patients 
T10,13,17), two of whom showed absent uptake on RIS; and to 
perinatal asphyxia in one (patient T4). Cause was not established 
in the remaining seven patients.
Figure 3. Ultrasound image showing perithyroid oedema due 
to allo- immune thyroiditis in an infant born to a mother with 
very elevated TSH- receptor antibodies (>405 u l−1). Neither 
subjective evaluation nor objective measurement was possible 
in this patient.
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Diagnostic challenge has not yet been carried out in two patients, 
related to ongoing problems—complex cardiac disease and 
Down syndrome (SU1), and neurodisability related to a 15q 
deletion (SU2).
Intraobserver error for objective measurement of 
thyroid ultrasound volume (Table 3)
Mean ± SD (%) differences in right lobe volume, left lobe volume 
and combined volumes between the first and second sessions 
were 0.07 ± 0.13 (9.7%), 0.06 ± 0.10 (10%) and 0.11 ± 0.23 (8.3%) 
respectively.
Intraobserver difference was greater—0.38 ml (37.5%)—in the 
seven infants with large glands. This difference fell to 0.16 ml 
(15.7%) after excluding two patients in whom thyroid length had 
to be estimated by extrapolation, the lobes being too large to be 
viewed on a single image (Figure 4).
Interobserver error for subjective measurement of 
thyroid ultrasound volume
The two observers were concordant for 24, one category apart 
for 8 and discordant for 4. These latter patients comprised 
borderline- large vs small (agreed borderline- large) in the index 
patient with PAX8 mutation (patient P11, Figure 2); and small vs 
normal (agreed borderline- normal) in three.
Concordance between objective and subjective 
evaluation of thyroid volume (see Figure 5, Tables 
1&2)
Figure  5 shows the comparison between subjective and objec-
tive evaluation of thyroid size related to the final diagnostic 
category in 2019. The two modalities were concordant (14) or 
one category apart (8) for 22 patients. However, subjective and 
objective evaluation was discordant (two categories apart) for 14 
patients—P7,8,11,12; T2,3,5,6,7,10,11,13,15; and SU2 (denoted 
with a † symbol in Tables 1 and 2).
In eight patients, thyroid size was assessed as large (7) or 
borderline- large (1) on subjective evaluation but objectively 
of normal (5), borderline- small (2) or small (1) volume. In all 
these infants (denoted with a * symbol in Tables 1 and 2), thyroid 
shape was altered, with the normal curves of the anterior margin 
of the thyroid gland (Figure 1) being replaced by a single curve 
(Figures 2, 6 and 7 corresponding to patients P11, P7 and T6) 
giving a bowed appearance and hence an impression of enlarge-
ment or bulkiness. Moreover, the thyroid isthmus was judged to 
be enlarged in four of these patients (P7,P8, T1 and T3).
In the remaining six infants with discordance between objec-
tive and subjective assessment (patient P12, Table  1; patients 
Table 3. Intraobserver error for blind evaluation of measured thyroid volume on ultrasound by the same two observers on two 
separate occasions in 36 newborn infants with elevated thyroid stimulating hormone levels on newborn screening, and eutopic 
glands
Gland volume [n=]
Mean volume
[n=]
Intra observer difference
Mean % differenceMean ± SD Median
Small (<0.8 ml) 0.55
[n = 17]
0.049 ± 0.035 0.0421 4.9
Borderline- small (0.8–1.0 ml) 0.86
[n = 4]
0.047 ± 0.05 0.0341 4.7
Normal (1.01–2.19 ml) all patients 1.49
[n = 8]
0.0812 ± 0.077 0.0527 8.1
Normal (1.01–2.19 ml) all patients, excluding infants 
in whom extrapolation was needed
1.40
[n = 6]
0.0969 ± 0.083 0.085 9.6
Borderline- large (2.2–2.4) [n = 0]
Large (>2.4 ml all patients 3.30
[n = 7]
0.3755 ± 0.45 0.1295 37.5
Large (>2.4 ml) excluding infants in whom 
extrapolation needed
3.08
[n = 5]
0.1579 ± 0.1609 0.1043 15.7
Mean gland volumes between sessions 1 and 2 were grouped according to size categories derived from the data of Perry et al.11
Figure 4. Enlarged thyroid in an infant with dyshormonogen-
esis due to a thyroid peroxidase gene defect (patient P6 in 
Table  1). The thyroid lobe is too large to be shown on one 
image so that its length had to be estimated by extrapolation.
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T10,11,15 and SU2 in Table 2), the gland was subjectively normal 
but objectively small (<0.8 ml) on measurement. Gland shape 
was normal in all these patients in whom measured thyroid 
volume ranged between 0.52 and 0.76 ml.
DiscussiOn
This study both confirms the importance of carrying out thyroid 
imaging in suspected CH and highlights the current limitations 
of assessing gland size with thyroid ultrasound according to 
conventional methods.
Diagnostic imaging, by identifying the presence/absence and 
location of thyroid tissue, is essential for the management 
and counselling in babies with TSH elevation on newborn 
screening. Thyroid ultrasound is reliable for detecting a gland in 
situ, provided that the diagnostic trap of misinterpreting non- 
thyroidal fatty tissue in the thyroid fossa as thyroid dysplasia is 
avoided.19 However, radioisotope imaging is required if thyroid 
ectopia is to be securely identified.15,16
If athyreosis or ectopia is demonstrated, lifetime treatment with 
L- T4 will be required. However, if a eutopic gland is identified 
then there is a significant chance of transient thyroid dysfunc-
tion—34.5% of patients in an Italian study of 86 children,8 and 17 
of the 36 patients (45.9%) in this study. Thus, while the finding of 
a eutopic gland encourages the clinician to seek a specific diag-
nosis (e.g. gene mutation) where possible, it mandates critical 
evaluation of the diagnosis of permanent CH, with diagnostic 
challenge at 3 years in selected cases, as recommended by current 
European guidelines.7 It is therefore to be hoped that diagnostic 
imaging, whether by ultrasound, isotope scanning or both, will 
be more consistently performed throughout Scotland and the 
rest of the United Kingdom in the future.
To date, studies and guidelines involving ultrasound assessment 
of eutopic thyroids have used terms such as ‘normal’ or ‘normally 
shaped’, ‘enlarged’ or ‘goitre’, and ‘hypoplastic’ or ‘morphologi-
cally abnormal’ without the systematic use of standards and 
cut- offs,7,10,20,21 relying on the interpretation of an experienced 
Figure 5. Chart comparing subjective evaluation with objective assessment of thyroid size in 36 infants referred with elevated 
thyroid stimulating hormone on newborn screening. Subjective size (small, small- normal, normal, large- normal and large) is shown 
on the x- axis and objective measurement of thyroid volume is shown on the y- axis. Individual patients are colour- coded according 
to diagnostic category.
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observer.10,21 This study challenges and critically examines this 
aspect of diagnostic imaging.
Concerning the diagnosis of dyshormonogenesis, our data show 
that this should not depend solely on measured thyroid volume 
which was well within the reference range at 1.75 ml in one of 
our patients with proven DUOX.2 mutation (patient P7, Table 1, 
Figure  6). Even if it were possible to measure thyroid volume 
accurately in CH infants with altered gland shape, applying rigid 
cut- offs would be unlikely to result in 100% sensitivity. We believe 
that it more appropriate to take account of additional factors 
such as uptake and apparent size on RIS, increased vascularity on 
ultrasound, and thyroglobulin levels, which are usually greatly 
elevated except in cases of Tg mutation (see patients P1and P4 
in Table 1). These factors, rather than size alone, are reflected in 
the criteria we have set for diagnosing dyshormonogenesis in the 
present study.
Equally, gland size cannot be used as the sole criterion for thyroid 
hypoplasia. A small thyroid gland may be normal, particularly in 
a small infant with transient TSH elevation. For this reason, we 
have defined thyroid hypoplasia strictly, as small or borderline- 
small gland volume in either permanent CH or in the presence of 
a gene disorder known to result in impaired thyroid size.
While the criteria and standards set in our study may be open to 
question and debate, they at least represent an attempt to bring 
rigour to an area of paediatric thyroid disease which has not, to 
date, received critical attention.
Intraobserver error for objective measurement and interobserver 
error for subjective assessment in this study are favourable. 
When thyroid volume was derived using a standard formula the 
data were reproducible, with an intraobserver error of less than 
10%. Accuracy was undermined when the gland was too large 
for one lobe to be visualised in a single field so that extrapolation 
was necessary (Figure 4), a problem highlighted by Ueda et al, 
who recommended measurement of lobe width and anteropos-
terior dimension/thickness but not length in neonates.22 While a 
larger footprint linear transducer would allow a wider field, this 
technique is not feasible in newborn infants, in whom the neck 
area is too small to access.
Subjective assessment of gland size was also reasonable in this 
study, the observers independently scoring either the same or 
only one category apart for 32 of the 36 (86.5%) cases.
By contrast, our study demonstrates a major problem of discor-
dance between subjective and objective assessment, affecting a 
significant number (14/36) of cases. This discordance concerns: 
(a) subjectively large glands scoring normal or even small for size 
on objective measurement; and (b) subjectively normal- sized 
glands scoring small on objective measurement.
In the former category, the principal factors causing discor-
dance were thyroid shape and size of isthmus. When the normal 
curves of the anterior margin of the thyroid gland (Figure 1) are 
replaced by a single curve, giving a bowed appearance (Figure 2), 
the presence of enlargement or bulkiness is suggested. This led 
to an erroneous subjective assessment in glands which were 
initially judged to be enlarged but were in fact mildly hypoplastic 
in association with PAX8 mutation, and mutation adjacent to the 
NKX2.1 gene (patient P11, Figure 2, patient T6, Figure 7).
However, objective assessment using standard methodology may 
also be confounded by altered gland shape, since the formula 
which assumes the shape of a prolate ellipsoid in each lobe may 
no longer apply. Also, the size of the isthmus, which is typi-
cally enlarged in cases of dyshormonogenesis (Figure 4), is not 
factored into the formula for thyroid volume measurement.
Figure 6. Ultrasound of infant with compound heterozygous 
DUOX.2 mutation (patient P7, Table 1), showing loss of normal 
curves of anterior margin of thyroid. Objective measurement 
of the gland at 1.75 ml falls within normal limits.
Figure 7. Ultrasound of infant with a variant of the brain–lung–
thyroid syndrome with mutation adjacent to the NKX2.1 gene 
(patient T6, Table 2). Subjective evaluation suggested a bulky 
gland attributable to a single, flattened, slightly curved ante-
rior border but measured volume was small- normal at 0.94 ml.
o PostScript
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Of note, there were six cases where subjective evaluation indi-
cated a normally shaped thyroid gland of normal size but in 
whom measured volume was up to 0.2 ml below our defined 
limit of 0.8 ml. Moreover, 7 of the 17 cases of transient CH 
showed measured volumes of <1 ml but normal size and 
normal shape on subjective examination (see patients T9-11, 
13–15, Table  2). This discrepancy might be partly accounted 
for by the relatively high reference range established for Scot-
tish data. Certainly, thyroid size was greater in Perry’s study 
than in comparable studies from countries such as Turkey,23 
Poland,24 China,25 Germany26 and Belgium27 (Table  4). 
Smoking has been shown to have a goitrogenic effect in adults, 
with increased thyroid size in the newborn of mothers who 
were smokers28 and neither smoking nor iodine status were 
evaluated in Perry’s study.11 Iodine status in Scottish mothers 
is currently the subject of a large clinical study and prelimi-
nary results suggest that fewer than 50% of a pregnant females 
sample population satisfy the World Health Organisation 
criteria of urinary iodine concentration ≥150 µg l−1 for iodine 
sufficiency29 (Combet, 2020 in preparation). Nevertheless, even 
according to Polish and German data, the thyroid volumes in 
11 of our transient cases are at the lower end of the reference 
range. It is possible, therefore, that some causes of transient 
CH, such as anti- thyroid antibodies may reduce gland size. This 
finding has implications for the follow up of infants with tran-
sient TSH elevation, who are currently discharged once thyroid 
function has normalised.
Improved methods are clearly needed for assessing thyroid size 
in suspected CH. At present, no reference data exist for thyroid 
isthmus thickness in healthy newborn infants. Also, existing 
reference data are for healthy, term neonates whereas some of the 
infants referred with TSH elevation are preterm and hence small. 
Establishing a ratio between lobe length and tracheal width could 
be helpful in factoring in birth size. Therefore, further normative 
population data which examines not only lobe volume, but also 
isthmus thickness and tracheal width, and which takes account 
of maternal smoking and iodine status, is recommended
Another approach would be to develop techniques for assessing 
total thyroid volume, rather than lobe size. Ying et al recom-
mend performing a three- dimensional scan,30 but this approach 
is not always readily accessible, has not been validated in the 
newborn, and will not help in deciding what equation to apply. 
Tracing around the gland on a single transverse image may be 
more accurate than assuming a standard shape and Shabana et al 
have suggested that interobserver variation could be reduced by 
applying this method.31
Table 4. Summary of normative thyroid ultrasound data in newborn infants (birth − 28 days) for thyroid lobe length, width, anter-
oposterior dimension and combined volume of both lobes in studies from Scotland, Poland, Turkey, China, Germany and Belgium
RIGHT LOBE LEFT LOBE
BOTH 
LOBES
Length (cm) Width (cm) Anteroposterior 
(cm)
Vol
(ml)
Length
(cm)
Width (cm) Anteroposterior
(cm)
Vol
(ml)
Vol
(ml)
Scotland, Perry et al 2002 (100 newborn) [π/6]. See reference 11
Mean (SD) 1.94
(0.24)
0.87
(0.15)
0.97
(0.16)
0.81
(0.23)
1.94
(0.24)
0.89
(0.16)
0.95
(0.17)
0.82
(0.24)
1.62
(0.41)
Range (0.9–2.5) (0.5–1.4) (0.6–2.0) (0.3–1.7) 0.9–2.4) (0.6–1.4) (0.7–1.9) 0.4–1.7) (0.7–3.3)
Poland, Mikolajczak et al 2014 (148 newborn) [π/6] See reference24
Mean (SD) 2.05 (0.15) 0.71 (0.1) 0.68 (0.075) 0.53 (0.1) 2.0 (0.155) 0.73 (0.104) 0.68 (0.07) 0.52 
(0.13)
1.05 (0.24)
(1.5–2.9) (0.5–1.0) (0.5–0.9) (0.2–0.9) (1.6–2.7) (0.5–1.0) (0.5–1.0) (0.3–1.0) (0.5–1.8)
Turkey, Kurtoglu et al. 2008 (100 term newborn) [0.479] See reference23
Mean 0.72 (0.9)
Range
China, Yao et al. 2010 (85 newborn) [0.479] See reference25
Mean 1.46 (0.27) 0.72 (0.14) 0.63 (0.11) 1.45 (0.23) 0.72 (0.13) 0.61 (0.13) 0.64 (0.27)
Range (0.7–2.1) (0.5–1.4) (0.44–0.99) 0.72–1.9 0.45–1.13 0.39–1.1 (0.27–1.85)
Germany, Klingmüller et al. 1992 (24 newborn) [π/6] See reference26
Mean (SD) 1.1 (0.7)
Range 0.4–3.5
Belgium, Chanoine et al 1991 (85 newborns) [π/6] See reference27
Mean (SD) 0.83 (0.38)
Range
The constant used to calculate thyroid volume is given as either π/6 (0.52) or 0.479.
11 of 12 birpublications.org/bjro BJR Open;2:20200001
BJR|OpenOriginal research: Subjective vs objective evaluation of thyroid size in CH
We conclude that both objective and subjective measurement 
of a eutopic thyroid gland are necessary; that neither method 
is entirely satisfactory due to the confounding effects of altered 
thyroid shape; and that a clear distinction between thyroid 
hypoplasia, normal size and thyroid enlargement are not always 
possible with ultrasound. Until better models for assessing 
thyroid size are available, we recommend using both subjec-
tive and objective assessment in evaluating thyroid volume. 
Our experience confirms that combining RIS with thyroid 
ultrasound is valuable.15,16 Finally, this study demonstrates the 
value of securing a precise molecular genetic diagnosis where 
possible, and the importance of long- term follow- up.
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